Evaluation of the Effects of Thyrotropin Releasing Hormone (TRH) Therapy on Regional Cerebral Blood Flow in the Cerebellar Variant of Multiple System Atrophy Using 3DSRT

Journal of Neuroimaging

Volumn 21, Issue 2, 2011, Pages 132-137

  Kimura, Noriyuki ^a   Kumamoto, Toshihide ^a   Masuda, Teruaki ^a   Nomura, Yuki ^a   Hanaoka, Takuya ^a   Hazama, Yusuke ^a   Okazaki, Toshio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

3DSRT; Brain perfusion SPECT; Cerebellar variant of multiple system atrophy; Regional cerebral blood flow; Thyrotropin releasing hormone

Indexed keywords

PROTIRELIN;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HORMONAL THERAPY; HUMAN; MALE; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CEREBELLAR DISEASES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; THYROTROPIN-RELEASING HORMONE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 79953055444     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00411.x     Document Type: Article

References (32)

1. Morley JE. Extrahypothalamic thyrotropin releasing hormone (TRH) - its distribution and its functions. Life Sci 1979;25:1539-1550.
2. Tanaka K, Ogawa N, Asanuma M, et al. Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury. Regul Pept 1997;18:173-178.
3. Yoshinari S, Hamano S, Tanaka M, et al. Alteration of regional cerebral blood flow to thyrotropin-releasing hormone therapy in acute encephalitis and encephalopathy during childhood. Eur J Paediatr Neurol 2006;10:124-128.
4. Nakamura R, Fujita M. Effect of thyrotropin-releasing hormone (TRH) on motor performance of hemiparetic stroke patients. Tohoku J Exp Med 1990;160:141-143.
5. Luo L, Yano N, Mao Q, et al. Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis 2002;4:97-103.
6. Takeuchi Y, Miyanomae Y, Komatsu H, et al. Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy. J Child Neurol 1994;9:287-289.
7. Sobue I, Yamamoto H, Konagaya M, et al. Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration. Lancet 1980;1:418-419.
8. Sobue I, Takayanagi T, Nakanishi T, et al. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations. J Neurol Sci 1983;61:235-248.
9. Kimura N, Kumamoto T, Masuda T, et al. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT. J Neurol Sci 2009;281:93-98.
10. Waragai M, Ogawara K, Takaya Y, et al. Efficacy of TRH-T for spinocerebellar degeneration-the relation between clinical features and effect of TRH therapy. Rinsho Shinkeigaku 1997;37:587-594.
11. Yabe I, Soma H, Takei A, et al. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. J Neurol Sci 2006;249:115-121.
12. Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002;125:1070-1083.
13. Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med 2006;24:538-544.
14. Tateno M, Utsumi K, Kobayashi S, et al. Usefulness of a blood flow analyzing program 3DSRT to detect occipital hypoperfusion in dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1206-1209.
15. Tateno M, Kobayashi S, Utsumi K, et al. Quantitative analysis of the effects of donepezil on regional cerebral blood flow in Alzheimer's disease by using an automated program, 3DSRT. Neuroradiol 2008;50:723-727.
16. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
17. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997;145:205-211.
18. Matsuda H, Tsuji S, Shuke N, et al. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1993;20:391-401.
19. Matsuda H, Yagishita A, Tsuji S, et al. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1995;22:633-637.
20. Lassen NA, Andersen AR, Friberg L, et al. The retention of [99mTc]-d, l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988;8:13-22.
21. Friberg L, Andersen AR, Lassen NA, et al. Retention of 99mTc-bicisate in the human brain after intracarotid injection. J Cereb Blood Flow Metab 1994;14:19-27.
22. Waragai M, Yamada T, Matsuda H. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases. J Neurol Sci 2007;260:57-64.
23. Matsuda H, Mizumura S, Nagao T, et al. Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol 2007;28:731-6.
24. Izumi Y, Fukuuchi Y, Ishihara N, et al. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease. Tokai J Exp Clin Med 1995;20:203-208
25. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004;127:2657-2671.
26. Ota S, Tsuchiya K, Anno M, et al. Distribution of cerebello-olivary degeneration in idiopathic late cortical cerebellar atrophy: clinicopathological study of four autopsy cases. Neuropathology 2008;28:43-50
27. Koskinen LO, Bill A. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit. Acta Physiol Scand 1984;122:127-136.
28. Koskinen LO. Effects of TRH on cerebral and peripheral blood flows; role of submesencephalic brain stem centres. Acta Physiol Scand 1986;128:277-288.
29. Abdo WF, van de Warrenburg BP, Munneke M, et al. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Neurology 2006;67:474-479.
30. Polinsky RJ, Brown RT, Burns RS, et al. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure. J Neurol Neurosurg Psychiatry 1988;51:914-919.
31. Cilia R, Marotta G, Benti R, et al. Brain SPECT imaging in multiple system atrophy. J Neural Transm 2005;112:1635-1645.
32. Rouiller EM, Liang F, Babalian A, et al. Cerebellothalamocortical and pallidothalamocortical projections to the primary and supplementary motor cortical areas: a multiple tracing study in macaque monkeys. J Comp Neurol 1994;345:185-213.